glibenclamide
Last reviewed 01/2018
Glibenclamide is an oral hypoglycaemic. It has a long duration of action and the relative risk of prolonged hypoglycaemia is therefore high. It is also relatively contraindicated in renal impairment as active metabolites accumulate.